Clinical Trial Update: A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing XW003 injection with semaglutide injection in Chinese adults with obesity; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Semaglutide injection (semaglutide)
• XW003 Injection (XW003)

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: Obesity, Weight Management | Phase 2 | Status: ACTIVE_NOT_RECRUITING